NASDAQ:APTX
Delisted

Aptinyx Stock Signals

etoro logo Buy APTX
*Your capital is at risk
$0.0960
+0 (+0%)
At Close: Mar 28, 2024

Latest Data & Signals Issued

Below are some of the latest signals issued for Aptinyx Inc

General

Signal Type Signal Value Data
Score 0.000 67 days ( -5.44 %
Last Price $0.0960 0 %
Performance History
7 Days
$0.0960 $0.0960
0%
30 Days
$0.0960 $0.0960
0%
12 Mos
$0.136 $0.0960
-29.36%

4/18

Active Buy Signals

Specific Signals

Short Term
Net score: 15.54
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.0960 - $0.0960
Trend - 3 mos 0 % High Width: 0 %
Pred. range - 3 mos N/A - N/A Low -100.00 % - -100.00 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Mar 27, 2024 - 2 days
RSI Short Pivot Signal Sell Very Low Jan 17, 2024 - 51 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 54.33
Signal Type Signal Value Importance Data
Trend - 12 mos -4.33 % Very High Width: 196.86 %
Pred. range - 12 mos $0.0448 - $0.133 High -53.36 % - 38.47 %
Short MA 12 mos Buy Very High Dec 13, 2023 - 73 days
Long MA 12 mos Buy Very High Dec 18, 2023 - 70 days
Short/Long MA 12 mos Buy Very High Dec 21, 2023 - 67 days
Pivot Long Sell Low Mar 27, 2024 - 2 days
RSI Long Pivot Signal Sell Low Jan 26, 2024 - 44 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT APTINYX INC
Aptinyx
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic peripheral neuropathy, as well as in Phase II/b clinical trial for treating fibromyalgia. It is also deve...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
13.43% Jun 05
TPR
$140.47
4.95% Jun 04
LITE
$905.00
1.83% Jun 01
RUN
$12.83
0.468% May 06
GLBE
$31.61
3.54% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE